‘Novel approach to cancer metabolism’ the target of Rising Tide Foundation partnership with Oxford University
The University will form a spinout company to take pioneering oncology research forward.
OMass Therapeutics Announces £27.5 Million Extended Series A Financing
Developing a pipeline of small molecule therapeutics for patients with immunological and genetic disorders.
Oxford Investment Opportunity Network and Oxford Angel Network join forces
Leading angel networks in Oxford merge to catalyse early-stage tech investment in the Oxford Cluster.
Prolific plants $1.2m seed to take on Amazon’s online research market
Y Combinator startup Prolific announces $1.2M seed round with participation from Pioneer Fund and prominent Silicon Valley Angel investors.
VR medical training enabled by Oxford Uni-backed LIFE app
New virtual reality medical training app LIFE uses HTC VIVE Focus Plus for training doctors and nurses to save lives.
New funds announced
Funds to transform research projects into investable propositions have been boosted with the addition of £5m from Oxford Sciences Innovation (OSI) into the existing University Challenge Seed Fund (UCSF).
OUI Q3 2019 Update
AI@Oxford round up, Oxford Cluster map launched and much more in OUI's regular update.
MiroBio launches with £27m Series A from leading life sciences investors
Oxford spinout developing novel therapeutics based on deep expertise in immune cell regulation.
Herbicide resistance crisis targeted by new Oxford tech firm MoA Technology
MoA Technology, borne out of Oxford University research, launches to confront the global herbicide resistance crisis with £6.3m Series A funding round.
Oxford Brain Diagnostics sets out with the goal of improving the treatment of Alzheimer’s by enabling early and accurate detection
The Oxford University spinout company launches to look inside the brain for novel markers of disease.
